skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Recently, 5i has supported members' suggestions to switch out of JNJ into something else given the legal difficulties that JNJ faces. I generally like to hold indefinitely; given this anticipated time frame, and my preference for safety and a good/growing dividend, do you think I should switch as well? Do you view the alternatives I've listed as less or more risky than JNJ overall? Are there non-pharmaceutical alternatives in the US healthcare space that would provide an equally secure and growing dividend that you would recommend? Thank you.
Read Answer Asked by Walter on August 08, 2018
Q: Hello, I am looking to add IHI to the healthcare allocation of my portfolio (10%) but would like to sell one existing holding first. Current healthcare related holdings are JNJ, ABBV, GUD and SIS (although I have SIS filed under Industrials). My question: which of JNJ and ABBV would you advise selling? Thank-you.
Read Answer Asked by Stephen on June 20, 2018
Q: Thinking of this one in replacement of GILD that i sold 2 weeks ago. low p/e and peg, nice dividend but high debt.Argus and S&P by applying comp p/e come up with a target of 84$. Does it deserve the p/e or cheap for a reason?
What is your view on this one ?
Any suggestion ?
(like everybody else: I know you don't cover US stocks... bla bla bla)
Thanks much!
Read Answer Asked by Denis on March 03, 2017
Q: My question is on Abbott Labs and Abbvie. I had 300 shares of Abbott and they split. Now I have 300 of Abbott and 300 of Abbvie. Should I hold both sell both or keep one over the other. I know that Humira comes off of patton in 2016 in US and 2017 in Europe. Should I sell Abbvie before then?
Read Answer Asked by Jimmy on December 15, 2013
Q: Can you please provide your opinion of AbbVie? It has done well since being spun off from Abbott Labs and pays a nice dividend. However, it is not followed by any of the research services that I subscribe to so I am not entirely comfortable holding it. With CML out of the picture, my only other healthcare holding is JNJ. Should I consider replacing ABBV with VRX or perhaps PLB? Thank you.
Read Answer Asked by Stephen on October 06, 2013
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!